Antiphospholipid syndrome (APS) is an acquired autoimmune disease characterized by
thromboembolic events, pregnancy morbidity, and the presence of antiphospholipid (aPL) …

The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by
arterial and/or venous thrombosis, pregnancy morbidity, and the presence of …

Anti-phospholipid syndrome (APS) is defined by recurrent arterial/venous thrombosis and/or
fetal losses in the persistent presence of anti-phospholipid antibodies (aPL). In in vivo …

The antiphospholipid syndrome (APS) is characterized by thrombosis and pregnancy
morbidity in the presence of antiphospholipid antibodies (aPL). Complement is a system of …

The presence of pathogenic antiphospholipid antibodies (aPL) is the characterizing feature
of the antiphospholipid syndrome (APS), mediating the recurrent pregnancy loss and …

Pathogenic antiphospholipid antibodies (aPL) are the driving factors of recurrent pregnancy
loss and thrombosis that characterize antiphospholipid syndrome (APS). Current evidence …

The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by an
elevated risk for arterial and venous thrombosis and pregnancy-related morbidity. Since the …

Antiphospholipid antibodies (aPL) are associated with the recurrent pregnancy loss and
thrombosis that characterizes the antiphospholipid antibody syndrome (APS). Although the …

Antiphospholipid syndrome (APLS) is a complex systemic disease with a wide variety of
clinical manifestations. In the obstetric population, recurrent early pregnancy loss, fetal loss …

The antiphospholipid syndrome (APS) is diagnosed by the combination of vascular
thrombosis and/or pregnancy morbidity and the detection of antiphospholipid antibodies …